Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
The journal of nutrition, health & aging
Metadata
Title
HIgh dietary and plasma levels of the omega-3 fatty acid docosahexaenoic acid are associated with decreased dementia risk: the rancho bernardo study
Authors
L. B. Lopez
Donna Kritz-Silverstein
Elizabeth Barrett-Connor
Publication date
01-01-2011
Publisher
Springer-Verlag
Published in
The journal of nutrition, health & aging / Issue 1/2011
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-011-0009-5

Other articles of this Issue 1/2011

The journal of nutrition, health & aging 1/2011 Go to the issue

OriginalPaper

How to manage recurrent falls in clinical practice: Guidelines of the French society of geriatrics and gerontology

OriginalPaper

Designing clinical trials for early (pre-dementia) Alzheimer’s disease: Determining the appropriate population for treatment

OriginalPaper

In epidemiological studies: Findings from the hertfordshire sarcopenia study (HSS)

OriginalPaper

Depressive symptoms are associated with food insufficiency and nutritional deficiencies in poor community-dwelling elderly people

OriginalPaper

Association between benzodiazepines and recurrent falls: A cross-sectional elderly population-based study

OriginalPaper

A practical approach to lipid management in the elderly

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits